GlassScriptPhysician profile
David C Champion
NPI 1326046004
$11,734.10
in general payments reported to CMS, 2019-2025
13 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $38.46 · 2022: $41.01 · 2023: $7,520 · 2024: $3,871 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,280.00 |
| Food and Beverage | $231.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Plasma INC. | $11,280.00 | 2023-2024 | |
| Alkermes, INC. | $96.81 | 2019-2025 | Aristada, Lybalvi |
| Otsuka America Pharmaceutical, INC. | $90.59 | 2019-2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $66.52 | 2019-2024 | Austedo Xr |
| Neurocrine Biosciences, INC. | $50.64 | 2019-2025 | |
| Vanda Pharmaceuticals INC. | $26.24 | 2025 | Fanapt |
| Takeda Pharmaceuticals U.S.A., INC. | $25.23 | 2020-2022 | |
| Argon Medical Devices, INC. | $18.97 | 2025 | Clot Management |
| Shire North American Group INC | $17.34 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.34 | 2019 | |
| Corium, LLC | $16.03 | 2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $15.64 | 2022 | |
| Indivior INC. | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Champion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.